Weight Management with Multiple Endocrine Neoplasia (MEN1 & MEN2) in South Africa
Multiple Endocrine Neoplasia (MEN) syndromes are rare hereditary tumour syndromes in which mutations in specific genes predispose individuals to develop tumours — typically benign but sometimes malignant — affecting multiple endocrine glands simultaneously. MEN type 1 (MEN1; MEN1 gene mutation) classically causes tumours of the parathyroid glands, anterior pituitary, and pancreatic/duodenal neuroendocrine cells (gastrinomas, insulinomas). MEN type 2 (MEN2; RET proto-oncogene mutation) encompasses MEN2A (medullary thyroid carcinoma, phaeochromocytoma, hyperparathyroidism) and MEN2B (medullary thyroid carcinoma, phaeochromocytoma, mucosal neuromas, Marfanoid habitus). MEN type 4 (MEN4; CDKN1B mutation) resembles MEN1 and is increasingly recognised. These are autosomal dominant conditions, meaning a first-degree relative of an affected person has a 50% chance of carrying the mutation. In South Africa, MEN syndromes are managed at academic hospitals by endocrinologists and surgeons, often in coordination with genetic counselling services. Weight management in MEN is uniquely complex because each tumour type produces its own hormonal disturbance — and patients may have multiple active tumours simultaneously, each pulling body weight in different directions. Surgery, radiation, and pharmacotherapy further alter metabolic state. This guide addresses the weight-relevant aspects of each major MEN component.
MEN1 Overview: The Three P's
MEN1 is often remembered by the "three P's" of affected glands:
Component
Prevalence in MEN1
Hormones Excess/Deficient
Weight Effect
Parathyroid tumours (hyperparathyroidism)
>95%
PTH excess leading to hypercalcaemia
Fatigue, muscle weakness, depression — all reduce activity; nephrolithiasis complications
Very thin Marfanoid habitus; intestinal ganglioneuromas cause chronic diarrhoea and malabsorption; weight maintenance is often the challenge, not weight loss
Familial MTC
MTC only (RET mutation without phaeochromocytoma or hyperparathyroidism)
Post-thyroidectomy hypothyroidism if under-replaced; MTC calcitonin-driven diarrhoea if bulky metastatic disease
Primary hyperparathyroidism (PHPT) from parathyroid tumours is the most common MEN1 feature. Excess parathyroid hormone (PTH) elevates serum calcium. The effects on weight and body composition are largely indirect:
Fatigue and weakness from hypercalcaemia and muscle dysfunction — reduces physical activity and drives weight gain
Depression and cognitive slowing from hypercalcaemia effects on the CNS — reduces motivation for diet and exercise
Nausea and anorexia in severe hypercalcaemia — causes weight loss
Osteoporosis and fracture risk — limits physical activity
Nephrolithiasis (kidney stones) — pain and hospitalisation
After successful parathyroid surgery, calcium normalises. Patients typically report significant improvement in energy, mood, and cognitive function — facilitating return to normal physical activity and dietary self-regulation. Many experience spontaneous weight normalisation following successful parathyroidectomy.
Calcium Restriction Is NOT Recommended in PHPT: A common misconception is that restricting dietary calcium reduces blood calcium in primary hyperparathyroidism. This is incorrect and potentially harmful — PTH continues to mobilise calcium from bones regardless of dietary intake, and very low calcium diets may actually stimulate more PTH secretion. Maintain normal dietary calcium (1,000–1,200 mg/day from food sources). Avoid calcium supplements unless directed by your specialist. Stay very well hydrated — 2.5 litres of water daily — to reduce kidney stone risk.
2. Gastrinoma (Zollinger-Ellison Syndrome) in MEN1
Gastrinomas are the most common pancreatic neuroendocrine tumour in MEN1 and cause Zollinger-Ellison Syndrome (ZES) — massive gastric acid hypersecretion driving peptic ulcers and secretory diarrhoea.
Chronic diarrhoea causes malabsorption of fat, protein, and fat-soluble vitamins (A, D, E, K) — leading to unintentional weight loss and nutritional deficiencies
Peptic ulcers reduce appetite — patients may avoid eating to prevent pain, accelerating weight loss
Post-surgical short bowel (if extensive pancreatic surgery required) causes severe long-term malabsorption
Medical management: High-dose proton pump inhibitors (PPIs — omeprazole, pantoprazole, esomeprazole) are first-line and dramatically reduce acid hypersecretion. Effective PPI therapy reduces diarrhoea and allows nutritional recovery. Somatostatin analogues (octreotide, lanreotide — Somatuline Autogel, available in SA through specialty pharmacies) are used to control hormone secretion and may stabilise tumour growth.
Diet During Active ZES: Small, frequent meals rather than large meals; low-fat diet to reduce diarrhoea; avoid foods that stimulate acid (spicy food, coffee, alcohol); supplement fat-soluble vitamins; ensure adequate calcium and magnesium (chronic PPI use over years depletes these minerals).
3. Insulinoma in MEN1
Insulinomas secrete insulin autonomously, causing recurrent hypoglycaemia. The weight effect of insulinoma is almost uniformly weight gain:
Hypoglycaemia drives hunger and overeating — particularly high-carbohydrate foods — to raise blood sugar rapidly
Patients learn to eat every 2–3 hours and keep glucose tablets or sweets constantly available, greatly increasing caloric intake
Hypoglycaemia-induced cortisol and adrenaline surges promote fat storage
Surgery (insulinoma resection, often laparoscopic pancreatectomy) typically resolves hypoglycaemia and allows caloric normalisation — but patients often need dietary support to de-adapt from the chronic defensive overeating pattern
4. Pituitary Tumours in MEN1
Each pituitary tumour type has distinct weight effects:
Pituitary Tumour
Hormone Excess
Weight Effect
Treatment Implications
Prolactinoma (most common)
Prolactin excess
Weight gain; metabolic syndrome; reduced libido; in women: amenorrhoea and oestrogen deficiency leading to bone loss
Dopamine agonists (cabergoline, bromocriptine) reduce prolactin and often improve weight; both available in SA
Somatotroph adenoma (acromegaly)
Growth hormone and IGF-1 excess
Increased organ and muscle mass; soft tissue swelling; insulin resistance; visceral fat accumulation; significant cardiovascular risk
Surgery (transsphenoidal), somatostatin analogues (octreotide/lanreotide), pegvisomant (GH receptor antagonist) — metabolic improvement follows hormone control
Corticotroph adenoma (Cushing's disease)
ACTH driving cortisol excess
Central (truncal/visceral) obesity; moon face; buffalo hump; muscle wasting; hypertension; diabetes; osteoporosis — classic Cushing's syndrome features
Surgery first-line; pasireotide (Signifor) second-line; bilateral adrenalectomy as last resort; post-remission weight management focuses on reversing glucocorticoid-induced changes
Non-functioning adenoma
Mass effect compressing normal pituitary
Hypopituitarism causing GH deficiency, hypothyroidism, secondary adrenal insufficiency, hypogonadism — all cause fatigue, weight gain, reduced muscle mass
Hormone replacement therapy (thyroxine, hydrocortisone, testosterone/oestrogen, GH if indicated) combined with diet and exercise
5. Phaeochromocytoma in MEN2
Phaeochromocytomas are catecholamine-secreting tumours of the adrenal medulla, occurring in 40–50% of MEN2A and most MEN2B patients. Their metabolic effects are dramatic:
Hyperglycaemia: Catecholamines suppress insulin secretion and stimulate glycogenolysis — elevated blood glucose and increased appetite follow
Episodic hypertensive crises: Sweating, palpitations, severe headache, hypertension — triggered by exercise, certain foods, emotional stress, or specific medications
Cardiomyopathy: Chronic catecholamine excess can damage the heart muscle over time
Phaeochromocytoma and Exercise: High-intensity exercise can trigger dangerous hypertensive crises in uncontrolled phaeochromocytoma. Until the tumour is surgically removed and blood pressure is controlled with alpha-blockers (phenoxybenzamine, doxazosin) followed by beta-blockers, vigorous exercise must be avoided. Walking and gentle yoga are generally acceptable with medical clearance.
Dietary considerations with phaeochromocytoma: Tyramine-rich foods can theoretically trigger catecholamine release. During the pre-operative period, moderate the intake of: aged cheeses, fermented meats, red wine, soy sauce, overripe fruits. In South Africa, this means limiting heavily aged cheeses, some aged biltong, certain red wines, and soy-based condiments until after successful surgery.
6. Medullary Thyroid Carcinoma (MTC) in MEN2
MTC secretes calcitonin and sometimes other peptides including CGRP and serotonin. Effects on weight:
Calcitonin-driven diarrhoea: High calcitonin levels indicate active MTC and cause watery diarrhoea, malabsorption, and weight loss in patients with metastatic or bulky disease
Post-thyroidectomy hypothyroidism: Total thyroidectomy is standard in MEN2; without adequate levothyroxine replacement, hypothyroidism causes weight gain, fatigue, and bradycardia
Kinase inhibitor therapy: Vandetanib (Caprelsa) and cabozantinib (Cabometyx) are approved for progressive metastatic MTC; both can cause significant weight loss, diarrhoea, and anorexia as side effects requiring nutritional support
Post-Surgical Nutrition in MEN
MEN patients often undergo multiple surgeries over their lifetime. Nutritional recovery after endocrine surgery depends on the procedure:
Surgery
Key Nutritional Consideration
SA-Specific Tips
Parathyroidectomy
"Hungry bone" syndrome — rapid calcium uptake by bones post-surgery; requires high calcium and vitamin D supplementation
Amasi (fermented milk), sardines, calcium supplements; daily sun exposure for D3 production; fortified plant milks from Pick n Pay or Woolworths
Distal pancreatectomy (insulinoma)
Risk of exocrine pancreatic insufficiency (fat malabsorption); may develop new-onset diabetes
Pancreatic enzyme replacement (Creon) with all fat-containing meals; low-fat diet initially; regular blood glucose monitoring
Whipple procedure (pancreaticoduodenectomy)
Severe malabsorption; pancreatic enzyme deficiency; diabetes; dumping syndrome
Small frequent meals; Creon with every meal; avoid high-sugar drinks immediately after meals (dumping); specialist dietitian input is essential
Total thyroidectomy (MTC)
Lifelong levothyroxine; risk of hypoparathyroidism causing hypocalcaemia post-operatively
Watch for post-op tingling/tetany (hypocalcaemia signs); calcium and active vitamin D (calcitriol) supplementation acutely; lifelong levothyroxine adherence critical
Adrenalectomy (phaeochromocytoma)
If bilateral: permanent adrenal insufficiency requiring lifelong hydrocortisone and fludrocortisone
Carry emergency hydrocortisone injection; wear medic alert bracelet; sick day rules are essential for life
Fluids monitored by hospital team post-operatively; long-term pituitary hormone replacement as indicated
General Diet and Lifestyle Approach for MEN Patients
Given the multi-system nature of MEN and the multiple concurrent hormonal disturbances, several general principles apply broadly:
Work with a dietitian familiar with endocrine disorders — a standard weight loss programme is not appropriate; your needs are highly individualised and change with each tumour and surgery
Anti-inflammatory diet — abundant vegetables, fruits, oily fish (pilchards, sardines, mackerel — affordable and widely available in SA), olive oil, legumes — reduces cardiovascular risk and inflammation
Adequate protein — 1.2–1.5 g/kg/day — preserves muscle mass during multi-system illness and post-surgery recovery; lean chicken, eggs, amasi, lentils, beans
High calcium foods — amasi, sardines eaten with bones, fortified plant milks, broccoli — important given hyperparathyroidism history and post-parathyroidectomy bone healing needs
Stay very well hydrated — 2.5 litres of water daily minimum; critical for kidney stone prevention and catecholamine stability
Rooibos tea — caffeine-free; does not trigger phaeochromocytoma symptoms; a safe and culturally familiar SA hot drink; high in antioxidants
Regular appropriate exercise — walking, resistance training, yoga — adapted to current surgical and disease status; vital for bone density, cardiovascular health, and mental wellbeing
Genetic Testing and Family Surveillance
MEN1 and MEN2 are hereditary — if you or a family member has been diagnosed, action is needed for the whole family:
All first-degree relatives (parents, siblings, children) should be offered genetic testing
In MEN2, RET mutation testing allows prophylactic thyroidectomy in childhood before MTC develops — potentially curative; timing depends on the specific RET codon mutation
Genetic counselling is available at academic hospitals in South Africa; National Health Laboratory Service (NHLS) performs genetic testing
Biochemical surveillance (calcium, gastrin, prolactin, chromogranin A, calcitonin as appropriate) typically begins in childhood for confirmed mutation carriers
MEN Support and Resources in South Africa
Endocrine Society of South Africa (ESSA): endocrine.org.za — specialist endocrinologist directory
Steve Biko Academic Hospital, Pretoria: Endocrinology and endocrine surgery; major public sector centre
Groote Schuur Hospital, Cape Town: Endocrinology and known MEN programme
Wits Donald Gordon Medical Centre, Johannesburg: Endocrine surgery and oncology
Rare Diseases South Africa (RDSA): rarediseases.co.za
AMEND (Association for Multiple Endocrine Neoplasia Disorders): amend.org.uk — comprehensive international patient resource including SA support contacts
MEN syndromes cause multiple simultaneous endocrine tumours — each with distinct, often opposing, effects on weight and metabolism
MEN1: parathyroid tumours (hypercalcaemia causing fatigue), gastrinomas (malabsorption and diarrhoea), insulinomas (hypoglycaemia driving overeating and weight gain), pituitary tumours (prolactinoma, acromegaly, or Cushing's)
MEN2: medullary thyroid cancer (calcitonin-driven diarrhoea), phaeochromocytoma (hypermetabolism and cardiovascular crisis risk), hyperparathyroidism in MEN2A
Post-surgical nutritional management is often as important as pre-surgical dietary adjustments — pancreatic surgery especially requires enzyme replacement and specialised dietary support
Uncontrolled phaeochromocytoma is a contraindication to vigorous exercise — pre-operative alpha-blockade is essential before any surgery
MEN syndromes are hereditary — genetic testing of first-degree relatives is medically important and potentially life-saving, particularly in MEN2
Always work with an endocrinologist-led multidisciplinary team; standard weight loss programmes are not appropriate without specialist input